logologo
QuantliQuantli

Bolt Biotherapeutics Inc

BOLT

NASDAQ

Biotechnology

$3.35

USD

+0.14 (+4.36%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $6.18M

Volume 16.0K

Price Target

$7.00$22.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $22.00 and a min estimate of $7.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$14.50

+$7.5 vs prior

Implied Upside

+332.8%

+223.9% vs prior

Analyst Covering

2

+1 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

67%

Most ratings are recent - from the last 3 months

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Michael G. King Jr.

Rodman & Renshaw

Buy

Initiated

2 months ago

Plus
Plus
Plus

Robert Burns

HC Wainwright & Co.

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

ENSC

Ensysce Biosciences Inc

$0.4000

+14.8%

ERNA

Ernexa Therapeutics Inc

$4.27

-0.7%

PMCB

PharmaCyte Biotech Inc

$0.5500

+0.2%

BRTX

BioRestorative Therapies Inc

$0.2300

+2.6%

ACXP

Acurx Pharmaceuticals Inc

$1.40

-5.7%

FBLG

Fibrobiologics Inc

$1.06

-7.8%

XBIO

Xenetic Biosciences Inc

$3.28

-0.3%

ALZN

Alzamend Neuro Inc

$1.55

+6.2%

CDIO

Cardio Diagnostics Holdings Inc

$2.04

+1.5%

DRMA

Dermata Therapeutics Inc

$1.46

-7.0%